Researchers analyzed data from 25 different studies involving 304 animal subjects. They looked at how plant-derived exosome-like nanoparticles, known as PELNs, affected the symptoms of ulcerative colitis. The study found that these particles helped mitigate weight loss and increased colon length in the animals tested.
The research also showed improvements in fecal consistency scores. Additionally, the treatment led to significant changes in diversity markers like the Chao index and Shannon index. These results suggest that the nanoparticles may have antioxidant and anti-inflammatory effects that help protect the intestinal barrier.
It is important to note that these findings come from preclinical animal studies only. Because the study was conducted on animals, it cannot confirm if these treatments will work for humans or exactly how they function in the human body. More research is needed before these results can be applied to human patients.
